UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________ FORM 10-Q _____________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36853 _____________________________________________________ ZILLOW G ...

Listings for luxury homes are seeing relatively more competition than homes in the market's midrange Luxury home values are up 3.9% year over year.  Inventory of luxury homes remains 46.9% below pre-pandemic levels, a bigger deficit than in the housing market overall.  Richmond has the hottest luxury housing market in the country. Austin is the only major market where luxury home values have declined throughout the past year.  SEATTLE, July 31, 2024 /PRNewswire/ -- Luxury home value growth, which has consis ...

The number of cities with 'million-dollar' starter homes has nearly tripled since 2019 The number of cities where a starter home is worth $1 million or more has grown from 84 five years ago to 237 today. Nearly half of these cities with "million-dollar" starter homes are in California. The typical starter home nationwide is worth less than $200,000. SEATTLE, July 25, 2024 /PRNewswire/ -- A million-dollar price tag no longer means lavish and luxurious living. In more than 200 U.S. cities, buyers will find a ...

SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully enrolled. EVANGELINE is a randomized non-inferiority trial of Atossa’s patented Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, and exemestane plus goserelin as a neoadjuvant treatment for pre-menopausal women with Grade 1 or 2 E ...

Competition is fading fast after the peak of this year's affordability-challenged home shopping season Monthly home value growth, while still positive, hit a 14-year low for June as competition relaxes. Inventory rose in all but five major metros while the nationwide deficit continues to shrink. Affordability challenges persist — new mortgages are affordable in just 11 of 50 major markets. SEATTLE, July 16, 2024 /PRNewswire/ -- Home listings are piling up as buyers step back from the peak of home shopping s ...

Rents are still most expensive in large coastal markets, but they are growing fastest in smaller markets in the Northeast and Midwest New York, San Jose and Boston are the most expensive rental markets. The fastest-growing rents are in more affordable markets in the Northeast and Midwest, led by Hartford and Cleveland.  Nationally, rents are up 3.5% year over year, the fastest annual growth since last July. SEATTLE, July 10, 2024 /PRNewswire/ -- While rents are most expensive in large coastal markets like N ...

Shares of Zillow Group (ZG) have gained 7.4% over the past four weeks to close the last trading session at $44.65, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $55.82 indicates a potential upside of 25%. The average comprises 22 short-term price targets ranging from a low of $35 to a high of $70, with a standard deviation of $9.27. While the lowest estimate indicates a declin ...

SEATTLE, June 28, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced protocol changes in the previously initiated study to evaluate Atossa’s proprietary (Z)-endoxifen in combination with abemaciclib (VERZENIO®), a cyclin-dependent kinase (CDK) 4/6 inhibitor marketed by Eli Lilly and Company. The study is investigating the combination as a neoadjuvant treatment in women with newly diagnosed Estrogen Receptor positive (ER+) / Human Epidermal Growth Fa ...

An insider just bought $100 million in stock.Zillow (Z -3.86%) has a chance to be one of the most disruptive companies in housing over the next decade. It can be the connective tissue between buyers, sellers, mortgages, and much more. In this video, Travis Hoium covers the bull case for the company and a recent insider buy of $100 million.*Stock prices used were end-of-day prices of June 22, 2024. The video was published on June 24, 2024. ...

That $127,750 down payment is what a household making the median income would need to put down when purchasing a typical U.S. home — valued at about $360,000 — so that the monthly mortgage payments take up no more than 30% of that household's monthly income.1 The enormous gap between the down payment needed now and five years ago underscores how the pandemic fueled a scorching-hot housing market, and why the rise in mortgage rates in the time since has cooled the market. Stubbornly high mortgage rates have ...